Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021

SELL
$16.86 - $19.67 $8.15 Million - $9.51 Million
-483,450 Closed
0 $0
Q3 2020

Nov 13, 2020

SELL
$15.4 - $20.16 $2.68 Million - $3.51 Million
-174,333 Reduced 26.5%
483,450 $8.39 Million
Q2 2020

Aug 14, 2020

BUY
$18.24 - $21.45 $12 Million - $14.1 Million
657,783 New
657,783 $12 Million
Q3 2019

Nov 13, 2019

SELL
$19.85 - $22.76 $12 Million - $13.8 Million
-605,251 Closed
0 $0
Q2 2019

Aug 08, 2019

SELL
$17.59 - $21.1 $994,204 - $1.19 Million
-56,521 Reduced 8.54%
605,251 $12.8 Million
Q1 2019

May 13, 2019

BUY
$18.01 - $20.11 $11.9 Million - $13.3 Million
661,772 New
661,772 $13.3 Million

Others Institutions Holding GRFS

About Grifols SA


  • Ticker GRFS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 678,910,976
  • Market Cap $5.33B
  • Description
  • Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...
More about GRFS
Track This Portfolio

Track Allianz Asset Management Gmb H Portfolio

Follow Allianz Asset Management Gmb H and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Allianz Asset Management Gmb H with notifications on news.